AV在线有码,欧美日韩超碰

Tsinghua Develops Long-Lived CAR-T Cells for Single-Dose Obesity & Diabetes Therapy Semaglutide Tsinghua University develops long-lived CAR-T cells that enable single-dose, long-term treatment of obesity and diabetes, offering a potential one-time therapy for chronic diseases.
Novo Nordisk H1 2025 Financial Reports Financial statements Novo Nordisk's Semaglutide generated $16.7B in H1 2025, surpassing Keytruda as the world's top-selling drug. Strong global and China sales drive growth despite competitive challenges.
The Expanding Benefits of GLP-1 Medicines Diabetes Discover the expanding benefits of GLP-1 drugs beyond diabetes and obesity, including improvements in heart, kidney, liver, joint, brain health, and more, as summarized by GLP-1 pioneer Daniel J. Drucker.
EU Confirms Vision Risk Tied to Semaglutide EMA EU regulators have confirmed a rare risk of vision loss linked to Novo Nordisk’s semaglutide, used in Wegovy and Ozempic. Drug labels will be updated to reflect the potential for NAION, a serious but very rare eye condition.
Chinese Original Weight Loss Drug Featured in NEJM Semaglutide "Mazdutide, a Chinese-developed dual GLP-1/GCG receptor agonist, shows strong weight loss efficacy and safety in a NEJM-published trial, outperforming semaglutide with fewer side effects.
Top 10 Best-Selling Drugs in Q1 2025 Market Trend Discover the top 10 best-selling drugs of Q1 2025. GLP-1 drugs dominate, with semaglutide and tirzepatide leading growth. Oncology and autoimmune treatments face challenges amid rising competition and patent expirations.
Oral Semaglutide: Clinical Trial Breakthroughs in Diabetes Treatment Semaglutide Discover how oral semaglutide (Rybelsus?) revolutionizes type 2 diabetes treatment with innovative formulation, clinical trial success, and promising benefits in glucose control, weight, and metabolic health.
70% Stop Medication, Oral GLP-1 as the Next Decisive Point? Semaglutide Explore the future of GLP-1 treatments as oral drugs emerge as a game changer amid high discontinuation rates. Discover key players, clinical results, and the challenges of developing small molecule GLP-1 receptor agonists.
Weight Loss Medications and Safety Concerns Weight loss drugs Explore the rise and fall of weight loss medications like Fenfluramine, Sibutramine, and more. Learn about the dangers, side effects, and FDA withdrawals of these drugs throughout history.
Semaglutide vs Tirzepatide in Weight Loss Semaglutide A head-to-head clinical trial shows Tirzepatide significantly outperforms Semaglutide in weight loss and waist reduction among obese non-diabetic adults, with superior efficacy and comparable safety.

<Pre12 Next >

Articles Archives

Hot Articles

All Categories

Agri & Industry Cosmetic Laboratory Pharmaceutical Food

国产91视频久久,亚洲综合色图在线观看,五月天操逼网,日韩色色AV,青青在线A片,亚洲最大色在线观看,欧美熟妇丝袜诱惑,青青操逼视频,日韩无码操出水